مقالة · مجلة · 2017

Characterisation of the HLA-DRB1*07:01 biomarker for lapatinib-induced liver toxicity during treatment of early-stage breast cancer patients with lapatinib in combination with trastuzumab and/or taxanes

C F Spraggs, L R Parham, L P Briley, Liling Warren, L S Williams, D J Fraser و16 آخرون

The Pharmacogenomics Journal

• وصول مغلق
• مع شركة
• دولي · 8 دول

انتقل إلى الناشر10.1038/tpj.2017.39